Results 11 to 20 of about 1,151,626 (269)

Age-specific prevalence, subtypes and risk factors of metabolic diseases in Chinese adults and the different patterns from other racial/ethnic populations

open access: yesBMC Public Health, 2022
Background Age has substantial influence on metabolic diseases patterns. Ethnic disparities of metabolic characteristics between Chinese and other populations also exist. Large-scale investigations of age-specific prevalence, subtypes and modifiable risk
Qiuyu Cao   +16 more
doaj   +1 more source

Fat mass to fat-free mass ratio and the risk of non-alcoholic fatty liver disease and fibrosis in non-obese and obese individuals

open access: yesNutrition & Metabolism, 2021
Context Body composition may explain partially why non-obese individuals still at the risk of developing non-alcoholic fatty liver disease (NAFLD).
Huajie Dai   +13 more
doaj   +1 more source

Dissecting Causal Relationships Between Gut Microbiota, Blood Metabolites, and Stroke: A Mendelian Randomization Study [PDF]

open access: yesJournal of Stroke, 2023
Background and Purpose We investigated the causal relationships between the gut microbiota (GM), stroke, and potential metabolite mediators using Mendelian randomization (MR).
Qi Wang   +17 more
doaj   +1 more source

Opposite causal effects of birthweight on myocardial infarction and atrial fibrillation and the distinct mediating pathways: a Mendelian randomization study

open access: yesCardiovascular Diabetology, 2023
Background Previous observational studies have documented an inverse association of birthweight with myocardial infarction (MI) but a positive association with atrial fibrillation (AF).
Lijie Kong   +17 more
doaj   +1 more source

Associations of body shapes with insulin resistance and cardiometabolic risk in middle-aged and elderly Chinese

open access: yesNutrition & Metabolism, 2021
Background We aimed to define refined body shapes by using multiple anthropometric traits that represent fat distribution, and evaluate their associations with risk of insulin resistance (IR) and cardiometabolic disorders in a Chinese population. Methods
Yulin Zhou   +14 more
doaj   +1 more source

Roles of gut microbiota in atrial fibrillation: insights from Mendelian randomization analysis and genetic data from over 430,000 cohort study participants

open access: yesCardiovascular Diabetology, 2023
Background Gut microbiota imbalances have been suggested as a contributing factor to atrial fibrillation (AF), but the causal relationship is not fully understood.
Huajie Dai   +18 more
doaj   +1 more source

Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 diabetes: a real-world single-centre study

open access: yesCardiovascular Diabetology, 2021
Background The triglyceride-glucose index (TyG index) has been proposed as a simple and reliable alternative insulin resistance (IR) marker, while the homeostasis model assessment for IR (HOMA-IR) is the most frequently used index.
Shujie Wang   +8 more
doaj   +1 more source

Higher scanning frequency is correlated with less fear of hypoglycemia in type 1 diabetes patients using isCGM

open access: yesFrontiers in Endocrinology, 2022
BackgroundFrequent scanning of intermittently scanned continuous glucose monitoring (isCGM) devices is associated with improvements in glycemic indices. Limited data is available for its correlation with fear of hypoglycemia (FOH), an established factor ...
Jerzy Hohendorff   +17 more
doaj   +1 more source

Phosphate Metabolism in Cardiorenal Metabolic Disease [PDF]

open access: yesCardiorenal Medicine, 2011
Hyperphosphatemia is a major risk factor for cardiovascular disease, abnormalities of mineral metabolism and bone disease, and the progression of renal insufficiency in patients with chronic renal disease. In early renal disease, serum phosphate levels are maintained within the ‘normal laboratory range’ by compensatory increases in phosphaturic ...
Deepashree, Gupta   +4 more
openaire   +2 more sources

Risk of subclinical atherosclerosis across metabolic transition in individuals with or without fatty liver disease: a prospective cohort study

open access: yesNutrition & Metabolism, 2023
Background Metabolic dysfunction is a major determinant in the progression of fatty liver disease. It is pivotal to evaluate the metabolic status and subsequent transition in fatty liver population and to identify the risk of subclinical atherosclerosis.
Zhuojun Xin   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy